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Edited by Felix WielandAbstract Mast cells are important players in innate immunity
and mediate allergic responses. Upon stimulation, they release
biologically active mediators including histamine, cytokines
and lysosomal hydrolases. We used permeabilized rat basophilic
leukaemia cells as model to identify R-SNAREs (soluble NSF
(N-ethylmaleimide-sensitive fusion protein)) mediating exocyto-
sis of hexosaminidase from mast cells. Of a complete set of re-
combinant mammalian R-SNAREs, only vesicle associated
membrane protein (VAMP8)/endobrevin consistently blocked
hexosaminidase release, which was also insensitive to treatment
with clostridial neurotoxins. Thus, VAMP8, which also mediates
fusion of late endosomes and lysosomes, plays a major role
in hexosaminidase release, strengthening the view that mast
cell granules share properties of both secretory granules and
lysosomes.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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In mammals, many diﬀerent cell types have the capacity to
undergo regulated exocytosis. These cells contain specialized
storage organelles that are released in response to an increase
in a second messenger, usually Ca2+. Recently, it has become
apparent that regulated exocytosis is more widespread and in-
volves organelles previously thought to be specialized for the
degradative pathway such as late endosomes and lysosomes
[1,2].
Exocytotic membrane fusion is mediated by soluble NSF (N-
ethylmaleimide-sensitive fusion protein) (SNARE) proteins.
SNAREs are small membrane proteins characterized by a
stretch of amino acids arranged in heptad repeats, referred
to as a SNARE motif, usually adjacent to a C-terminal trans-
membrane domain. When appropriate sets of SNAREs meet,
the previously unstructured SNARE motifs form highly stable
complexes consisting of elongated a-helical bundles arrangedAbbreviations: SNARE, soluble NSF (N-ethylmaleimide-sensitive
fusion protein) attachment protein receptor; VAMP, vesicle associated
membrane protein; RBL, rat basophilic leukaemia; SLO, streptolysin
O; BoNT/D, botulinum neurotoxin D; TeNT, tetanus neurotoxin
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doi:10.1016/j.febslet.2007.06.057in coiled-coils. SNARE assembly takes place between
SNAREs in juxtaposed membranes, and proceeds from the
N-terminus to the C-terminal membrane anchors, thus tying
the membranes together and initiating fusion. Each SNARE
complex consists of four SNARE motifs belonging to evolu-
tionarily conserved families termed Qa-, Qb-, Qc-, and R-
SNARE motifs, respectively. Although individual SNAREs
(mammals have more than 35) can operate in more than one
fusion event, it appears that individual fusion events are med-
iated by distinct SNARE complexes [3,4]. Best characterized is
the SNARE complex involved in neuronal exocytosis includ-
ing synaptobrevin/vesicle associated membrane protein
(VAMP2), SNAP-25 (with two SNARE motifs – Qb, Qc –
and lacking a transmembrane domain) and syntaxin 1. How-
ever it is unclear which SNAREs are participating in other
exocytotic events. Mammals possess only nine diﬀerent
R-SNAREs, three of which are highly homologous to each
other (synaptobrevin/VAMP1, synaptobrevin 2, and cellubre-
vin/VAMP3). Recently, it has been shown that another
R-SNARE, VAMP8/endobrevin, mediates regulated exocyto-
sis of secretory granules in exocrine glands and in platelets
[5,6]. This ﬁnding was a surprise because VAMP8 was previ-
ously assigned to the fusion of late endosomes and lysosomes
[7,8]. Thus, these ﬁndings provide an unexpected link between
lysosomes and organelles generally considered as bona-ﬁde
secretory granules, despite their diﬀerent biogenesis.
In the present study, we have investigated which of the mam-
malian R-SNAREs is involved in exocytosis of mast cells.
Mast cells are pivotal initiators of immediate type allergic reac-
tions such as asthma and allergic rhinitis [9]. Beyond their det-
rimental role in allergic reactions, beneﬁcial functions of mast
cells in innate immunity against parasites and bacterial infec-
tions are well documented [10–12].
Due to their physiological and clinical importance, the
mechanisms underlying mast cell exocytosis are of consider-
able interest. The secretory granules of mast cells possess prop-
erties of both secretory granules and lysosomes. In addition to
granule-speciﬁc mediators such as serotonin and histamine,
they contain lysosomal proteins including hexosaminidase
and lysosome membrane proteins (LAMPs) as well as cyto-
kines [1,9,13].
Previously, the SNAREs SNAP-23 (Qbc) and syntaxin 3 and
4 (Qa) have been linked to mast cell exocytosis [14–16]. Fur-
thermore, a variety of R-SNAREs including synaptobrevin
2, cellubrevin, VAMP7 and endobrevin were detected in mast
cells [14,15], but due to their ubiquitous presence in all tissuesblished by Elsevier B.V. All rights reserved.
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expression patterns. Thus, the identity of the vesicular R-
SNARE(s) involved in mast cell exocytosis is still unknown.
Using permeabilized rat basophilic leukaemia cells (RBL) as
a model, we report here that VAMP8 is directly involved in
mast cell degranulation.2. Materials and methods
2.1. Cell culture and reagents
RBL-2H3 cells were maintained as described [17]. Other reagents
and sources were: GTPcS; Roche, glutathione-Sepharose; Pharmacia,
Ni-NTA agarose; Qiagen, 1,3-diamino-2-propanol-N-N 0-N 0-tetraacetic
acid (DPTA); Fluka, Mag-Fura-2; Invitrogen, Fluoreszeinisothiocy-
anat (FITC)-labelled Annexin V; Invitrogen. Antibodies speciﬁc for
synaptobrevin 2, cellubrevin, and VAMP8 were from Synaptic Systems
(Go¨ttingen, Germany). All other reagents were purchased from Sigma.
2.2. Cloning and recombinant proteins
Rat cDNA for Ykt6 (encoding residues 137–198, GenBank acces-
sion number AY881621) and VAMP5 (for residues 1–73, GenBank
accession number AF054826), were ampliﬁed as described [18] or with
primers 5 0-CTGGATCCATGGCAGGGAAAGAATTGGAG and 5 0-
CGTCTAGATTAGTAGACCCGGCACCGGAT, respectively, and
were cloned into the XbaI/SacI and BamHI/XbaI sites, respectively,
of the expression vector pGEX-KG (GE Healthcare). cDNA for the
VAMP7core fragment (aa-1–73, VAMP7c) was ampliﬁed as described
[19], and was subcloned into the NdeI/ BamHI sites of pET-28a vector
(New England Biolabs). Recombinant Streptolysin O (SLO) from a
pMal-c29 expression construct (kindly provided by G. Ahnert-Hilger
[20]), was expressed in Escherichia coli and isolated over a starch-Se-
pharose 6B column (GE Healthcare) followed by puriﬁcation over a
Ceramic Hydroxyapatite column (BioRad). Toxin activity was deter-
mined by measuring the hemolytic titer of rabbit erythrocytes and by
titration using toxin-treated RBL cells and Trypan blue staining.
GST-tagged VAMP5 and Ykt6c, and His-tagged VAMP7c, were
puriﬁed by aﬃnity binding to glutathione-Sepharose or Ni2+-agarose,
followed by ion-exchange chromatography (Mono-Q or Mono-S) on
an FPLC system (GE Healthcare). Synaptobrevin 2 (residues 1–96),
Cellubrevin (aa 1–82), VAMP4 (residues-1-117), VAMP8, GST-tagged
Sec22 (residues 1–194), wild-type a-SNAP and a-SNAP L294A were
produced as described previously [7,21–23].
2.3. Release of hexosaminidase from permeabilized RBL-cells
RBL cells were cultured and permeabilized as described [24], with
minor modiﬁcations. Cells were permeabilized with 1.2 lg/ml SLO in
permeabilization buﬀer (120 mM KCl, 20 mM potassium acetate,
20 mM HEPES, 4 mM MgCl2, 0.1% BSA, pH 7.2) for 6 min at
37 C to introduce the selected proteins (after rebuﬀering in permeabi-
lization buﬀer), after which cells were stimulated with permeabilization
buﬀer supplemented with 10 lM free Ca2+, 10 mM DTPA, 100 lM
GTPcS and an ATP-regenerating system (1 mM ATP, 3 mM creatine
phosphate and 1 lM creatine kinase, pH 7.2), for 25 min at 37 C.
Reactions were stopped with 1 mM EGTA, the supernatants were har-
vested, and the remaining cell pellets lysed with 0.2% Triton-X 100 in
permeabilization buﬀer for 30 min on ice. Free Ca2+ was adjusted
using a standardized buﬀering system [25].
b-Hexosaminidase activity was determined after removal of cell deb-
ris by centrifugation, with a ﬂuorescence-based enzyme assay [26].
Samples were analyzed in a Genios Pro microtiter ﬂuorescence plate
reader (Tecan) using 360 nm excitation and 450 nm emission ﬁlters.
Hexosaminidase release was expressed as percent of total hexosamini-
dase (sum of hexosaminidase in supernatant and cell lysates), with
stimulation being corrected for basal release from unstimulated sam-
ples. The data show means and the standard deviation (S.D.) of at least
seven separate cell incubations.2.4. Toxin treatment and analysis
SLO-permeabilized RBL cells were incubated for 6 min at 37 C
with the light chain of Botulinum neurotoxin D (BoNT/D) (1 lM)
or tetanus neurotoxin (TeNT) (2.5 lM). Cells were washed and lysedin 2% Triton-X 100 in PBS. The lysates were centrifuged at
13.000 rpm at 4 C. Thirty-ﬁve micrograms of protein of each sample
were analyzed by SDS–PAGE and immunoblotting using alkaline-
phosphatase conjugated secondary antibodies for detection (BioRad).3. Results
3.1. Ca2+-dependent secretion of hexosaminidase from SLO-
permeabilized RBL cells is mediated by SNARE proteins
Permeabilization of secretory cells by SLO has been widely
used for manipulating the cytoplasmic protein and solute com-
position while maintaining structural integrity of the cell
[27,28]. Many secretory cells including RBL cells maintain
their capacity of Ca2+-dependent exocytosis after permeabili-
zation and appropriate substitution with ATP and cytosolic
proteins [24,29]. As shown in Fig. 1A, addition of Ca2+ and
a non-hydrolyzable GTP analog (which augments exocytosis
in mast cells) [30] elicited a robust exocytotic response, with
approximately 30% (means 29% ± 7) of total hexosaminidase
content released in 25 min, whereas release in unstimulated
controls was always below 3% (median 1.6% ± 0.6), in good
agreement with previous publications [16,31].
To examine whether exocytosis is mediated by SNARE pro-
teins, we ﬁrst tested whether N-ethylmaleimide (NEM) inhibits
exocytosis. NEM is known to inactivate NSF, a hexameric
ATPase that is needed for dissociating and activating SNARE
complexes. NEM induced a dose dependent inhibition of mast
cell exocytosis up to 93% ± 2 (Fig. 1B), conﬁrming previous
observations on non-permeabilized rat peritoneal mast cells
[32,33]. As NEM is a non-speciﬁc alkylating agent, it cannot
be excluded that the inhibition is caused by alkylating target
proteins other than NSF. Therefore, we incubated cells with
an a-SNAP mutant that is unable to activate NSF. a-SNAP
binds to SNARE complexes before NSF can bind, and since
it has no other targets an eﬀect of the mutant is generally ac-
cepted as conclusive evidence for SNARE-dependence [23].
As shown in Fig. 1B, the inactive mutant but not the wild-type
protein inhibited b-hexosaminidase release in mast cells by
about 50%. Together, these experiments show that permeabili-
zed RBL cells are a suitable model to address SNARE func-
tion in degranulation.
3.2. Identiﬁcation of the R-SNARE VAMP8 as primarily
responsible for b-hexosaminidase release in SLO-
permeabilized RBL cells
To identify the R-SNARE(s) mediating exocytosis of hexos-
aminidase, we employed soluble fragments of all known mam-
malian R-SNAREs as competitive inhibitors. We have shown
previously that this approach can be used to functionally iden-
tify SNARE complexes in a given fusion step, provided an
appropriate cell-free assay is available [22]. In this approach,
the endogenous, membrane-anchored SNARE is outcompeted
by the soluble fragment, forming SNARE complexes with the
partner SNAREs that are thus inactivated for fusion. Since
NSF remains active, the inhibition is counteracted by dis-
assembly, and accordingly inhibition is not expected to be
complete.
The recombinant R-SNAREs synaptobrevin, cellubrevin,
VAMP4, VAMP8/endobrevin and Ykt6c, expressed and puri-
ﬁed after tag removal, GST-tagged VAMP5 and Sec22b, and
His-tagged VAMP7c, were employed in highly puriﬁed form
Fig. 1. Exocytotic release of hexosaminidase from RBL cells is mediated by SNAREs. (A) Exocytosis from SLO-permeabilized RBL cells is triggered
by addition of Ca2+ and GTPcS. (B) NEM and the dominant negative mutant a-SNAP-L294A, but not wild-type a-SNAP inhibit stimulated
exocytosis of hexosaminidase. Values are plotted as percent inhibition, with control levels in the presence of Ca2+ and GTPcS being deﬁned as 0%,
and basal release in the absence of second messengers as 100% inhibition.
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batch was nevertheless active in competing with the endoge-
nous protein in the fusion of early endosomes (not shown,
see [22]).
These proteins were added to the SLO-permeabilized cells at
concentrations between 15 and 45 lM, conditions previously
found to be eﬀective in inhibiting fusion of endosomes [8,22].
Of all R-SNAREs tested, VAMP8 was by far the most potent,
reaching inhibition levels of more than 30% (Fig. 3). Most
other SNAREs including VAMP4, VAMP5, VAMP7, Ykt6Fig. 2. Recombinant puriﬁed R-SNARE proteins used in this study,
separated by SDS–PAGE and visualized by Coomassie Blue staining.
Most proteins migrate as single bands, except for VAMP4 where some
breakdown is visible.and Sec22, did not inhibit signiﬁcantly. Only synaptobrevin 2
and cellubrevin showed some inhibitory activity (Fig. 3B,C).
To test whether these SNAREs are indeed contributing to
the release of b-hexosaminidase, we employed the endopro-
tease activity of the clostridial neurotoxins BoNT/D and TeNT
that selectively cleave and inactivate both proteins [34,35]. No
inhibition of exocytosis was observed with either of the toxins
whereas incubation with VAMP8, carried out in parallel, was
again eﬃcient as inhibitor (Fig. 4A). To verify that the endo-
proteases had actually cleaved their targets, we analyzed the
cell lysates after toxin incubation for synaptobrevin 2, cellub-
revin and VAMP8 by immunoblotting (Fig. 4B). Both toxins
eﬀectively cleaved cellubrevin and synaptobrevin 2 whereas,
as expected, VAMP8 remained unaﬀected. We conclude that
VAMP8 serves as the major R-SNARE in the exocytosis of
hexosaminidase-containing granules from mast cells.4. Discussion
In the present study, we have identiﬁed the R-SNARE
VAMP8 as major R-SNARE involved in exocytosis of hexos-
aminidase-containing granules from mast cells.
Mast cells contain distinct types of secretory granules that
diﬀer in their content and probably also in their membrane
composition. In RBL cells hexosaminidase activity was identi-
ﬁed in two diﬀerent subcellular fractions of mast cell granules.
The ﬁrst contained histamine and hexosaminidase activity, the
second fraction was amine-free, contained procathepsin D and
Fig. 3. Inﬂuence of diﬀerent R-SNAREs on hexosaminidase release from SLO-permeabilized RBL cells. All values are plotted as percent inhibition
(see legend to Fig. 1). (A) Increasing concentrations of VAMP8 clearly lead to an inhibition of hexosaminidase secretion, whereas no signiﬁcant eﬀect
can be observed for VAMP4 (D), VAMP5 (E), the VAMP7 SNARE motif (VAMP7c) (F), the Ykt6 SNARE motif (Ykt6c) (G) or Sec22 (H). A
minor eﬀect of Synaptobrevin 2 (Syb2) (B) and Cellubrevin (Ceb) (C) could not be excluded.
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Fig. 4. Cleavage of synaptobrevin 2 and cellubrevin by the light chains
of tetanus toxin or botulinum neurotoxin D does not inhibit evoked
exocytosis of hexosaminidase from SLO-permeabilized RBL cells.
Virtually no eﬀect is seen on release (A) although both proteins were
quantitatively cleaved by both toxins (B,C). In contrast, no cleavage of
VAMP8 (D), used as control, was observed.
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other R-SNAREs participate in the exocytosis of granule sub-
populations previously shown to be diﬀerentially regulated
[36]. However, we were unable to detect any inﬂuence of other
R-SNAREs on hexosaminidase release. This is particularly
noteworthy for the ‘‘classical’’ exocytotic SNAREs synaptob-
revin and cellubrevin. Neither competition by recombinant
protein nor destruction of these SNAREs by clostridial toxin
proteases had any measurable eﬀect on exocytotic release of
hexosaminidase. It should be noted, however, that platelets
derived from VAMP8 knockout mice partially retained the
ability of calcium-dependent exocytosis, which in contrast to
wild-type platelets was sensitive to tetanus toxin [6]. Thus, it
is possible that synaptobrevin or cellubrevin may substitute
for the ‘‘primary’’ R-SNARE VAMP8 in its absence.
With which Q-SNAREs does VAMP8 interact at the plasma
membrane? In the fusion of late endosomes, VAMP8 forms
complexes with the SNAREs syntaxin 7 (Qa), syntaxin 8
(Qb), and vti1b (Qc) [3]. However, it is unlikely that these
SNAREs mediate exocytosis since they are primarily localized
to intracellular membranes. Thus it is possible that VAMP8 in-
stead interacts with SNAP23 (a Qbc-SNARE shown previ-
ously to be involved in mast cell exocytosis [14,16,37]) and
with one of the plasma membrane syntaxins. For instance,
overexpression of syntaxin 4 was shown to inhibit exocytosis
in RBL cells. Furthermore, SNAP23 and syntaxin 4 coprecip-
itate with VAMP8, but also with synaptobrevin and cellubre-
vin, suggesting that these SNAREs preferentially interact
with each other. Thus, VAMP8 is likely another example of
the functional promiscuity of R-SNAREs as previously dem-
onstrated in yeast membrane traﬃc [3]. Furthermore, the iden-tiﬁcation of the endosomal/lysosomal VAMP8 as a major R-
SNARE mediating release of hexosaminidase from mast cells
lends support to the concept that secretory granules of mast
cells share basic properties with lysosomes and thus may be
considered as secretory lysosomes.Acknowledgements: We thank K. Wiederhold, D. Zwilling, W. Anto-
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